Winolap 5 mg Sun Pharmaceuticals Industries
| Features | |
| Active substance | Olopatadine |
| Also known as | Opatanol |
| Blood pressure | No significant impact |
| Chemical name | 11-[(Z)-3-(Dimethylamino)propylidene]-6-11-dihydrodibenz[b,e]oxepin-2-acetic acid |
| Dosage (medical) | For allergic conjunctivitis - 0.1% ophthalmic solution, one drop in each affected eye twice a day |
| Dosage (sports) | Not applicable |
| Effects | Reduces histamine-induced symptoms like itching, redness, and swelling |
| Formula | C_21H_23NO_3 |
| Half-life | Approximately 12 hours |
| Hepatotoxicity | Low risk |
| Lab Test | Not specifically required for monitoring olopatadine |
| Main action | Histamine H1 receptor antagonist |
| Side effects | Mild taste, headache, sore throat, nasal dryness or irritation |
| Storage conditions | Store at room temperature, away from moisture and light |
| Strength | 5mg |
| Substance class | Antihistamine |
| Trade name | Patanol, Pataday |
| Use in sports | Not typically used in sports |
| Water Retention | No significant effect |
| Manufacturer | Sun Pharma Laboratories Ltd. |
| Packing | 10 tabs/blister |